Ariad Pharmaceuticals Inc
ARIA
ARIA was delisted on the 15th of February, 2017.
172 hedge funds and large institutions have $812M invested in Ariad Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 55 reducing their positions, and 26 closing their positions.
40% more call options, than puts
Call options by funds: $14.1M | Put options by funds: $10.1M
2% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 55
1% more capital invested
Capital invested by funds: $801M → $812M (+$11M)
8% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 26
2% less funds holding
Funds holding: 175 → 172 (-3)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$6.68M |
| 2 |
Renaissance Technologies
New York
|
+$4.94M |
| 3 |
PC
PointState Capital
New York
|
+$4.92M |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.23M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$32M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.11M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.96M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.63M |
| 5 |
DCM
Dynamic Capital Management
St. Helier,
Jersey
|
-$3.41M |
ARIA Hedge Fund Activity: Q4 2015 in Review
172 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q4 2015, worth a combined $812M — up 1.4% from $801M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of ARIA and 24 opened new positions — a net loss of 2 holders — while 55 trimmed existing stakes and 56 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $6.68M. The largest seller was Putnam Investments, cutting an estimated $32M.
- 172 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q4 2015, down from 175 in Q3 2015.
- Funds reported $812M of Ariad Pharmaceuticals Inc stock for Q4 2015, up 1.4% quarter-over-quarter.
- 24 funds opened new Ariad Pharmaceuticals Inc positions in Q4 2015 and 26 closed out, a net change of -2 holders.
- The largest Ariad Pharmaceuticals Inc buyer in Q4 2015 was D.E. Shaw & Co, an estimated $6.68M added.
- The largest Ariad Pharmaceuticals Inc seller in Q4 2015 was Putnam Investments, an estimated $32M sold.
Based on aggregated 13F filings for Q4 2015.